vs

Side-by-side financial comparison of IQVIA (IQV) and Synopsys (SNPS). Click either name above to swap in a different company.

IQVIA is the larger business by last-quarter revenue ($4.4B vs $2.3B, roughly 1.9× Synopsys). Synopsys runs the higher net margin — 19.9% vs 11.8%, a 8.1% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs 10.3%). Synopsys produced more free cash flow last quarter ($605.2M vs $561.0M). Over the past eight quarters, Synopsys's revenue compounded faster (16.9% CAGR vs 8.1%).

IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.

Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.

IQV vs SNPS — Head-to-Head

Bigger by revenue
IQV
IQV
1.9× larger
IQV
$4.4B
$2.3B
SNPS
Growing faster (revenue YoY)
SNPS
SNPS
+40.3% gap
SNPS
50.6%
10.3%
IQV
Higher net margin
SNPS
SNPS
8.1% more per $
SNPS
19.9%
11.8%
IQV
More free cash flow
SNPS
SNPS
$44.2M more FCF
SNPS
$605.2M
$561.0M
IQV
Faster 2-yr revenue CAGR
SNPS
SNPS
Annualised
SNPS
16.9%
8.1%
IQV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IQV
IQV
SNPS
SNPS
Revenue
$4.4B
$2.3B
Net Profit
$514.0M
$448.7M
Gross Margin
71.0%
Operating Margin
14.4%
5.4%
Net Margin
11.8%
19.9%
Revenue YoY
10.3%
50.6%
Net Profit YoY
17.6%
-59.7%
EPS (diluted)
$2.97
$2.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IQV
IQV
SNPS
SNPS
Q4 25
$4.4B
$2.3B
Q3 25
$4.1B
$1.7B
Q2 25
$4.0B
$1.6B
Q1 25
$3.8B
$1.5B
Q4 24
$4.0B
$1.5B
Q3 24
$3.9B
$1.5B
Q2 24
$3.8B
$1.5B
Q1 24
$3.7B
$1.6B
Net Profit
IQV
IQV
SNPS
SNPS
Q4 25
$514.0M
$448.7M
Q3 25
$331.0M
$242.5M
Q2 25
$266.0M
$345.3M
Q1 25
$249.0M
$295.7M
Q4 24
$437.0M
$1.1B
Q3 24
$285.0M
$408.1M
Q2 24
$363.0M
$292.1M
Q1 24
$288.0M
$449.1M
Gross Margin
IQV
IQV
SNPS
SNPS
Q4 25
71.0%
Q3 25
78.1%
Q2 25
80.2%
Q1 25
81.4%
Q4 24
78.3%
Q3 24
23.5%
80.9%
Q2 24
22.6%
79.4%
Q1 24
22.1%
80.0%
Operating Margin
IQV
IQV
SNPS
SNPS
Q4 25
14.4%
5.4%
Q3 25
13.5%
9.5%
Q2 25
12.6%
23.5%
Q1 25
13.0%
17.3%
Q4 24
15.8%
20.3%
Q3 24
14.1%
23.6%
Q2 24
13.6%
22.8%
Q1 24
13.5%
21.8%
Net Margin
IQV
IQV
SNPS
SNPS
Q4 25
11.8%
19.9%
Q3 25
8.1%
13.9%
Q2 25
6.6%
21.5%
Q1 25
6.5%
20.3%
Q4 24
11.0%
74.4%
Q3 24
7.3%
26.7%
Q2 24
9.5%
20.1%
Q1 24
7.7%
27.2%
EPS (diluted)
IQV
IQV
SNPS
SNPS
Q4 25
$2.97
$2.44
Q3 25
$1.93
$1.50
Q2 25
$1.54
$2.21
Q1 25
$1.40
$1.89
Q4 24
$2.41
$7.13
Q3 24
$1.55
$2.61
Q2 24
$1.97
$1.88
Q1 24
$1.56
$2.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IQV
IQV
SNPS
SNPS
Cash + ST InvestmentsLiquidity on hand
$2.1B
$3.0B
Total DebtLower is stronger
$13.5B
Stockholders' EquityBook value
$6.5B
$28.3B
Total Assets
$29.9B
$48.2B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IQV
IQV
SNPS
SNPS
Q4 25
$2.1B
$3.0B
Q3 25
$2.0B
$2.6B
Q2 25
$2.2B
$14.3B
Q1 25
$1.9B
$3.8B
Q4 24
$1.8B
$4.1B
Q3 24
$1.7B
$2.0B
Q2 24
$1.7B
$1.7B
Q1 24
$1.6B
$1.3B
Total Debt
IQV
IQV
SNPS
SNPS
Q4 25
$13.5B
Q3 25
$14.3B
Q2 25
$10.1B
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IQV
IQV
SNPS
SNPS
Q4 25
$6.5B
$28.3B
Q3 25
$6.2B
$27.6B
Q2 25
$5.8B
$9.9B
Q1 25
$6.0B
$9.3B
Q4 24
$6.1B
$9.0B
Q3 24
$7.0B
$7.7B
Q2 24
$6.7B
$7.2B
Q1 24
$6.3B
$6.7B
Total Assets
IQV
IQV
SNPS
SNPS
Q4 25
$29.9B
$48.2B
Q3 25
$28.7B
$48.2B
Q2 25
$28.6B
$23.8B
Q1 25
$27.3B
$13.0B
Q4 24
$26.9B
$13.1B
Q3 24
$27.2B
$11.6B
Q2 24
$26.4B
$11.0B
Q1 24
$26.6B
$10.6B
Debt / Equity
IQV
IQV
SNPS
SNPS
Q4 25
0.48×
Q3 25
0.52×
Q2 25
1.01×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IQV
IQV
SNPS
SNPS
Operating Cash FlowLast quarter
$735.0M
$639.7M
Free Cash FlowOCF − Capex
$561.0M
$605.2M
FCF MarginFCF / Revenue
12.9%
26.8%
Capex IntensityCapex / Revenue
4.0%
1.5%
Cash ConversionOCF / Net Profit
1.43×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$2.1B
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IQV
IQV
SNPS
SNPS
Q4 25
$735.0M
$639.7M
Q3 25
$908.0M
$671.0M
Q2 25
$443.0M
$275.4M
Q1 25
$568.0M
$-67.5M
Q4 24
$885.0M
$562.8M
Q3 24
$721.0M
$455.4M
Q2 24
$588.0M
$476.6M
Q1 24
$522.0M
$-87.8M
Free Cash Flow
IQV
IQV
SNPS
SNPS
Q4 25
$561.0M
$605.2M
Q3 25
$772.0M
$632.4M
Q2 25
$292.0M
$219.8M
Q1 25
$426.0M
$-108.2M
Q4 24
$721.0M
$558.4M
Q3 24
$571.0M
$415.4M
Q2 24
$445.0M
$438.2M
Q1 24
$377.0M
$-128.2M
FCF Margin
IQV
IQV
SNPS
SNPS
Q4 25
12.9%
26.8%
Q3 25
18.8%
36.3%
Q2 25
7.3%
13.7%
Q1 25
11.1%
-7.4%
Q4 24
18.2%
37.3%
Q3 24
14.7%
27.2%
Q2 24
11.7%
30.1%
Q1 24
10.1%
-7.8%
Capex Intensity
IQV
IQV
SNPS
SNPS
Q4 25
4.0%
1.5%
Q3 25
3.3%
2.2%
Q2 25
3.8%
3.5%
Q1 25
3.7%
2.8%
Q4 24
4.1%
0.3%
Q3 24
3.9%
2.6%
Q2 24
3.7%
2.6%
Q1 24
3.9%
2.4%
Cash Conversion
IQV
IQV
SNPS
SNPS
Q4 25
1.43×
1.43×
Q3 25
2.74×
2.77×
Q2 25
1.67×
0.80×
Q1 25
2.28×
-0.23×
Q4 24
2.03×
0.51×
Q3 24
2.53×
1.12×
Q2 24
1.62×
1.63×
Q1 24
1.81×
-0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IQV
IQV

Segment breakdown not available.

SNPS
SNPS

License And Maintenance$940.7M42%
Other$640.0M28%
Design IP Segment$407.1M18%
KR$236.9M11%
Sales Based Royalties$30.1M1%

Related Comparisons